MEKINIST
Analogs of MEKINIST
Find cheaper analogs and generic equivalents for MEKINIST.
Active Ingredient: TRAMETINIB
Product Overview
About MEKINIST
MEKINIST is a prescription medication containing the active ingredient Trametinib, a kinase inhibitor used in the treatment of certain types of cancer. It is specifically designed to target and inhibit the activity of the MEK protein, which plays a crucial role in the development and progression of cancer cells.
Key Benefits & Uses
- Treatment of unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
- Treatment of unresectable or metastatic melanoma with a BRAF V600 mutation
- Combination therapy with other medications for the treatment of unresectable or metastatic melanoma
Active Ingredient & Action
Trametinib, the active ingredient in MEKINIST, works by selectively inhibiting the activity of the MEK protein, which is involved in the MAPK/ERK signaling pathway. This pathway is critical for the growth and survival of cancer cells. By inhibiting MEK, Trametinib helps to slow down or stop the growth of cancer cells, thereby reducing tumor size and alleviating symptoms.
Important Notes
MEKINIST is available only by prescription and should be used under the guidance of a qualified healthcare professional. Patients taking MEKINIST should be closely monitored for signs of adverse effects, including skin rash, diarrhea, and liver damage. It is essential to follow the recommended dosage and administration instructions to minimize the risk of side effects.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.